Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer

por Haura, Eric B., Tanvetyanon, Tawee, Chiappori, Alberto, Williams, Charles, Simon, George, Antonia, Scott, Gray, Jhanelle, Litschauer, Sharon, Tetteh, Leticia, Neuger, Anthony, Song, Lanxi, Rawal, Bhupendra, Schell, Michael J., Bepler, Gerold
Publicado 2010

A phase I, pharmacokinetic and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors

por Gray, Jhanelle E., Haura, Eric, Chiappori, Alberto, Tanvetyanon, Tawee, Williams, Charles C., Pinder-Schenck, Mary, Kish, Julie A., Kreahling, Jenny, Lush, Richard, Neuger, Anthony, Tetteh, Leticia, Akar, Angela, Zhao, Xiuhua, Schell, Michael J., Bepler, Gerold, Altiok, Soner
Publicado 2014

Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

por Gibney, Geoffrey T., Kudchadkar, Ragini R., DeConti, Ronald C., Thebeau, Melissa S., Czupryn, Maria P., Tetteh, Leticia, Eysmans, Cabell, Richards, Allison, Schell, Michael J., Fisher, Kate J., Horak, Christine E., Inzunza, H. David, Yu, Bin, Martinez, Alberto J., Younos, Ibrahim, Weber, Jeffrey S.
Publicado en Clin Cancer Res (2014)

Combined BRAF and HSP90 inhibition in patients with unresectable BRAF V600E mutant melanoma

por Eroglu, Zeynep, Chen, Y. Ann, Gibney, Geoffrey T., Weber, Jeffrey S., Kudchadkar, Ragini R., Khushalani, Nikhil I., Markowitz, Joseph, Brohl, Andrew S., Tetteh, Leticia F., Ramadan, Howida, Arnone, Gina, Li, Jiannong, Zhao, Xiuhua, Sharma, Ritin, Darville, Lancia N.F., Fang, Bin, Smalley, Inna, Messina, Jane L., Koomen, John M., Sondak, Vernon K., Smalley, Keiran S.M.
Publicado en Clin Cancer Res (2018)